CD24 is a novel target of chimeric antigen receptor T cells for the treatment of triple negative breast cancer

Peiwei Yang, Yu Fan, Zheng Yao, Ding Xu, Hanmei Xu, Juan Zhang

Cancer Immunology Immunotherapy · 2023 · 21 citations · 30 references

DOIFull text

Open access

Concepts

References

30